Epigenome-modifying tools in asthma

Epigenomics. 2015;7(6):1017-32. doi: 10.2217/epi.15.53. Epub 2015 Oct 7.

Abstract

Asthma is a chronic disease which causes recurrent breathlessness affecting 300 million people worldwide of whom 250,000 die annually. The epigenome is a set of heritable modifications and tags that affect the genome without changing the intrinsic DNA sequence. These marks include DNA methylation, modifications to histone proteins around which DNA is wrapped and expression of noncoding RNA. Alterations in all of these processes have been reported in patients with asthma. In some cases these differences are linked to disease severity and susceptibility and may account for the limited value of genetic studies in asthma. Animal models of asthma suggest that epigenetic modifications and processes are linked to asthma and may be tractable targets for therapeutic intervention.

Keywords: DNA methylation; T cell; asthma; epigenetics; histone modification; miRNA; therapeutics.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acetylation / drug effects
  • Animals
  • Asthma / drug therapy
  • Asthma / genetics*
  • Asthma / metabolism
  • DNA Methylation
  • Epigenesis, Genetic*
  • Epigenomics* / methods
  • Gene Expression Regulation / drug effects
  • Histone Deacetylase Inhibitors / pharmacology
  • Histone Deacetylase Inhibitors / therapeutic use
  • Histones / metabolism
  • Humans
  • Methylation
  • MicroRNAs / genetics
  • Molecular Targeted Therapy

Substances

  • Histone Deacetylase Inhibitors
  • Histones
  • MicroRNAs